High levels of antimicrobial coresistance among extended-spectrum-β- lactamase-producing Enterobacteriaceae

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 5, 2005, Pages 2137-2139

  Schwaber, Mitchell J ^a   Navon Venezia, Shiri ^a   Schwartz, David ^a   Carmeli, Yehuda ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTERIACEAE; NONHUMAN; PRIORITY JOURNAL;

BETA-LACTAMASES; BETA-LACTAMS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS, TEACHING; MICROBIAL SENSITIVITY TESTS; PLASMIDS;

EID: 18244382543     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.5.2137-2139.2005     Document Type: Article

References (17)

1. Bell, J. M., J. D. Turnidge, A. C. Gales, M. A. Pfaller, and R. N. Jones. 2002. Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn. Microbiol. Infect. Dis. 42:193-198.
2. Chopra, I., A. J. O'Neill, and K. Miller. 2003. The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist. Updates 6:137-145.
3. Einhorn, A. E., M. M. Neuhauser, D. T. Bearden, J. P. Quinn, and S. L. Pendland. 2002. Extended-spectrum beta-lactamases: frequency, risk factors, and outcomes. Pharmacotherapy 22:14-20.
4. Fierer, J., and D. Guiney. 1999. Extended-spectrum beta-lactamases: a plague of plasmids. JAMA 281:563-564.
5. Gruteke, P., W. Goessens, J. van Gils, P. Peerbooms, N. Lemmens-den Toom, M. van Santen-Verheuvel, A. van Belkum, and H. Verbrugh. 2003. Patterns of resistance associated with integrons, the extended-spectrum β-lactamase SHV-5 gene, and a multidrug efflux pump of Klebsiella pneumoniae causing a nosocomial outbreak. J. Clin. Microbiol. 41:1161-1166.
6. Jacoby, G. A., N. Chow, and K. B. Waites. 2003. Prevalence of plasmid-mediated quinolone resistance. Antimicrob. Agents Chemother. 47:559-562.
7. Kaye, K. S., H. S. Gold, M. J. Schwaber, L. Venkataraman, Y. Qi, P. C. De Girolami, M. H. Samore, G. Anderson, J. K. Rasheed, and F. C. Tenover. 2004. Variety of β-lactamases produced by amoxicillin-clavulanate-resistant Escheirchia coli isolated in the northeastern United States. Antimicrob. Agents Chemother. 48:1520-1525.
8. Navon-Venezia, S., O. Hammer-Münz, D. Schwartz, D. Turner, B. Kuzmenko, and Y. Carmeli. 2003. Occurrence and phenotypic characteristics of extended-spectrum β-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests. J. Clin. Microbiol. 41:155-158.
9. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement. M100-S14, p. 24, Table 2A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Opal, S. M., K. H. Mayer, and A. A. Medeiros. 2000. Mechanisms of bacterial resistance, p. 236-258. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 5th edition. Churchill Livingstone, Philadelphia, Pa.
11. Oteo, J., J. Campos, and F. Baquero. 2002. Antibiotic resistance in 1962 invasive isolates of Escherichia coli in 27 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2001). J. Antimicrob. Chemother. 50:945-952.
12. Paterson, D. L., L. Mulazimoglu, J. M. Casellas, W. C. Ko, H. Goossens, A. Von Gottberg, S. Mohapatra, G. M. Trenholme, K. P. Klugman, J. G. McCormack, and V. L. Yu. 2000. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin. Infect. Dis. 30:473-478.
13. Schlesinger, J., S. Navon-Venezia, I. Chmelnitzky, O. Hammer-Münz, A. Leavitt, H. S. Gold, M. J. Schwaber, and Y. Carmeli. 2005. Extended-spectrum beta-lactamases among Enterobacter isolates in Tel Aviv, Israel. Antimicrob. Agents Chemother. 49:1150-1156.
14. Schwaber, M. J., P. M. Raney, J. K. Rasheed, J. W. Biddle, P. Williams, J. E. McGowan, Jr., and F. C. Tenover. 2004. Utility of NCCLS guidelines for identifying extended-spectrum β-lactamases in non-Escherichia coli and non-Klebsiella spp. of Enterobacteriaceae. J. Clin. Microbiol. 42:294-298.
15. Shimizu, K., T. Kumada, W.-C. Hsieh, H.-Y. Chung, Y. Chong, R. S. Hare, G. H. Miller, F. J. Sabatelli, and J. Howard. 1985. Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob. Agents Chemother. 28:282-288.
16. Spanu, T., F. Luzzaro, M. Perilli, G. Amicosante, A. Toniolo, G. Fadda, and The Italian ESBL Study Group. 2002. Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to β-lactams and other antimicrobial drugs. Antimicrob. Agents Chemother. 46:196-202.
17. Wang, M., D. F. Sahm, G. A. Jacoby, and D. C. Hooper. 2004. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob. Agents Chemother. 48:1295-1299.